Breaking barriers: cbdmd's research validates safe cbd upper dose

Charlotte, north carolina--(newsfile corp. - september 22, 2023) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa) (the "company"), one of the nation's leading providers of premium cannabidiol (cbd) products, today announced the publication of the company's safety data supporting a safe upper dose of its proprietary broad spectrum cbd blend. the data was published in regulatory toxicology and pharmacology.
YCBD Ratings Summary
YCBD Quant Ranking